The China-funded plant will be the first in Central Asia to produce drugs from blood plasma
Tashkent
Samarkand will open the first pharmaceutical plant for the production of drugs from blood plasma, the press service of the Ministry of Health of Uzbekistan reports.
The Ministry held talks with the Chinese delegation, as a result of which the parties reached an agreement on the implementation of an investment project for $250 million in the Urgut free economic zone.
The plant will be the first in Central Asia to produce drugs from blood plasma, which will cover the demand within the country and will serve to reduce imports.
The need for high-quality blood components has increased dramatically in recent years, which is explained by the introduction of complex surgical operations, the ministry explained. For example, a liver transplant requires up to 30 liters of blood plasma.
In total, 128 billion soums were allocated for the development of hematology and blood transfusion services in Uzbekistan. Now 67 blood-based drugs are mainly imported into the republic from abroad.
Earlier it was reported that honorary donors in Uzbekistan will triple their remuneration. The President also decreed to introduce privileges for holders of the corresponding badge.
____________
Courtesy: Central Asian Light (Posted on June 28, 2023)
